The problem of resistant bacteria is illustrated by what it has done to pneumococcal meningitis. The treatment you get today is considerably different from what you got a decade ago, because of the potential for resistant strains that require new or more expensive drugs. Thus, some people hope it will take bacteria longer to become resistant to it, because nature has never experienced it before. Zyvox could be used for adults with certain types of pneumonia or skin infections that normally show a lot of resistance. But it will be most useful for treatment of something with the breathtaking name of vancomycin-resistant Enterococcus, or VRE, which is common in liver transplant patients.
Many doctors are likely to hold it in reserve.
There's a concern that if we burn this drug out when we don't really need it, it won't be there for us when something comes along for which we have no alternative.